Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia-Reference-Cited by-同舟云学术

Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia

Published:2011-12-01 Issue:6 Volume:6 Page:703-716
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Carpentier André,Labbé Sébastien¹,Grenier–Larouche Thomas¹,Noll Christophe¹

Affiliation:

1. Department of Medicine, Division of Endocrinology, Université de Sherbrooke & Centre de recherche clinique Etienne-Le Bel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Québec, Canada

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.11.60

Reference117 articles.

1. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of Type 2 diabetes. Diabetes 51(1), 7–18 (2002).

2. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87(7), 3023–3028 (2002).

3. McGavock JM, Lingvay I, Zib I et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116(10), 1170–1175 (2007).

4. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N. Engl. J. Med. 350(7), 664–671 (2004).

5. Kotronen A, Yki-Jarvinen H, Sevastianova K et al. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Obesity.(Silver Spring) 19(1), 23–28 (2010). n Characterization of the role of liver steatosis as a marker of insulin resistance.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota;Food Chemistry;2023-03

2. Update on Obesity: Induced Inflammation to Cause Cardiometabolic Diseases;The Indonesian Biomedical Journal;2022-06-28

3. Increased postprandial nonesterified fatty acid efflux from adipose tissue in prediabetes is offset by enhanced dietary fatty acid adipose trapping;American Journal of Physiology-Endocrinology and Metabolism;2021-06-01

4. 100th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism;American Journal of Physiology-Endocrinology and Metabolism;2021-04-01

5. Enlarged adipocytes from subcutaneous vs. visceral adipose tissue differentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity;Scientific Reports;2021-01-19